Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
Plos One
|
May 6, 2024
External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis
Eric H Sasso, Brent Mabey, Darl D Flake, et al.
Biomarkers in Medicine
|
July 10, 2015
Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma
M Bryan Warf, Placede G Fosso, Elisha Hughes, et al.
Journal of Clinical Psychopharmacology
|
April 17, 2025
Real-World Impact of Pharmacogenomic Testing on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder
Andria L Del Tredici, Holly L Johnson, Brady DeHart, et al.
JAMA Network Open
|
June 17, 2026
Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk
Yijia Sun, Timothy Simmons, James L Li, et al.
JCO Precision Oncology
|
September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay
Hatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Annals of Surgical Oncology
|
January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Hatem Soliman, Susanne Wagner, Darl D Flake, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 13, 2013
Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy
Stephen J Freedland, Leah Gerber, Julia Reid, et al.
Frontiers in Pharmacology
|
November 17, 2025
Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder
Daniel Hain, Andria L Del Tredici, Ryan B Griggs, et al.
Urologic Oncology
|
April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance
Daniel W Lin, E David Crawford, Thomas Keane, et al.
JCO Precision Oncology
|
May 7, 2025
Association of Polygenic-Based Breast Cancer Risk Prediction With Patient Management
Katherine Johansen Taber, Elisha Hughes, Alexander Gutin, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
Plos One
|
May 6, 2024
External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis
Eric H Sasso, Brent Mabey, Darl D Flake, et al.
Biomarkers in Medicine
|
July 10, 2015
Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma
M Bryan Warf, Placede G Fosso, Elisha Hughes, et al.
Journal of Clinical Psychopharmacology
|
April 17, 2025
Real-World Impact of Pharmacogenomic Testing on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder
Andria L Del Tredici, Holly L Johnson, Brady DeHart, et al.
JAMA Network Open
|
June 17, 2026
Polygenic Risk Scores for Breast Cancer Among African American Women With High Risk
Yijia Sun, Timothy Simmons, James L Li, et al.
JCO Precision Oncology
|
September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay
Hatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Annals of Surgical Oncology
|
January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Hatem Soliman, Susanne Wagner, Darl D Flake, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 13, 2013
Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy
Stephen J Freedland, Leah Gerber, Julia Reid, et al.
Frontiers in Pharmacology
|
November 17, 2025
Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder
Daniel Hain, Andria L Del Tredici, Ryan B Griggs, et al.
Urologic Oncology
|
April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance
Daniel W Lin, E David Crawford, Thomas Keane, et al.
JCO Precision Oncology
|
May 7, 2025
Association of Polygenic-Based Breast Cancer Risk Prediction With Patient Management
Katherine Johansen Taber, Elisha Hughes, Alexander Gutin, et al.
Page
of 7